touchEXPERT OPINIONS for touchRESPIRATORY

Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder. 

The expert:

• Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Chiesi USA, Inc. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: www.touchrespiratoryime.org/eo-on-improving-alpha-mannosidosis-patient-journey/

touchEXPERT OPINIONS for touchNEUROLOGY

Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder. 

The expert:

• Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Chiesi USA, Inc. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: www.touchneurologyime.org/eo-on-improving-alpha-mannosidosis-patient-journey/

touchMDT for touchONCOLOGY

 A medical oncologist and a pathologist discuss HER2 testing in patients with colorectal cancer, including when and how to test, and the interpretation of test results.

The multidisciplinary team:

• Medical oncologist: Prof. Andrea Sartore-Bianchi, Niguarda Cancer Center, Milan, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

touchMDT for touchONCOLOGY

A medical oncologist, advanced practice nurse and patient advocate discuss possible side effects of colorectal cancer treatments and how they can be managed in the multidisciplinary team setting.

The multidisciplinary team:

• Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

touchMDT for touchONCOLOGY

A medical oncologist, advanced practice nurse and patient advocate share their views on how the multidisciplinary team can support patients with HER2-positive colorectal cancer.

The multidisciplinary team:

• Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

touchMDT for touchONCOLOGY

Two medical oncologists discuss the latest clinical trial data for HER2-targeted treatments in colorectal cancer (CRC), how they utilize these agents in clinical practice, and what the future holds for HER2-targeting in CRC.

The multidisciplinary team:

• Medical oncologists: Dr Kristen Ciombor, Nashville, TN, USA and Prof. Andrea Sartore-Bianchi, Milan, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Seagen Inc. and is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/

touchPANEL DISCUSSION for touchONCOLOGY

Listen to a panel of leading experts discuss the emerging role of antibody-drug conjugates (ADCs) in the treatment of patients with non-small cell lung cancer (NSCLC), including the mechanistic rationale and role of biomarkers in patient selection, the latest efficacy and safety data, and dose-finding strategies for optimal use in NSCLC. 

The experts:

• Prof. Jarushka Naidoo, Beaumont RCSI Cancer Centre, Dublin, Ireland

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from AstraZeneca. This activity is provided by touchIME. 

For further information please visit: https://touchoncology.com/education/pd-navigating-the-nsclc-treatment-pathway-focus-on-adcs/

touchTALKS for touchONCOLOGY

Listen to a leading expert in higher-risk myelodysplastic neoplasms (HR-MDS) discuss the impact that emerging treatment options may have on clinical practice. Dr David Sallman covers the latest updates to the classification of HR-MDS, the mode of action of emerging therapeutic agents and the most recent clinical evidence on their efficacy and safety.

The expert:

• Dr David Sallman, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/hr-mds-emerging-treatments/

touchMDT for touchRESPIRATORY

Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma. 

The multidisciplinary team

• Paediatric immunologist: Dr Wanda Phipatanakul

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Sanofi and  Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma

touchMDT for touchIMMUNOLOGY

Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma. 

The multidisciplinary team:

• Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma